Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

New Drug for Cocaine Addiction
October 16, 2002

Share Share Email
Email
Print
Print
SubscribeSubscribe
Research Summary

A new drug under development could help people overcome cocaine addiction, HealthScout News reported Oct. 9.

Called Nocaine, the drug was developed through the Georgetown University Medical Center's Drug Discovery Program.

A recent study conducted by researchers at Georgetown University, the University of Mississippi, and the University of Texas evaluated Nocaine using laboratory animals. The researchers found that the animals tried harder to get doses of Nocaine, rather than a placebo saline solution. On the other hand, the animals worked harder to get doses of cocaine, rather than Nocaine.

"Our study results imply that Nocaine is a weak reinforcer, meaning that it provides some of cocaine's effects, but at a much lower level," said William L. Woolverton, a professor of psychiatry at the University of Mississippi Medical Center.

Previous studies by Georgetown's Drug Discovery Program also found that Nocaine reverses the neurologic effects linked to cocaine withdrawal and blocks cocaine's stimulant effect.

"Our studies have shown that Nocaine would likely blunt the aversive effects associated with cocaine abstinence, enabling addicts to gradually and safely withdraw from the drug," said Alan P. Kozikowski, professor of neurology and director of Georgetown's Drug Discovery Program.

The study is published in the October 2002 issue of the Journal of Pharmacology and Experimental Therapeutics.

Woolverton, W., Ranaldi, R., Wang, Z., Ordway, G., Paul, I., Petukhov, P., & Kozikowski, A. (2002) Reinforcing Strength of a Novel Dopamine Transporter Ligand: Pharmacodynamic and Pharmacokinetic Mechanisms. Journal of Pharmacology and Experimental Therapeutics, 303: 211-217.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.